http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012047645-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_724ce0acf92a69b2783ed3993dacb351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d8dc1fd2742ff4485c6d5e00b359169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_922700843667b161a5e542bed4177a18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae32abd99c869304e08f3771fc23e965
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a600e02ed36fd8c0fe341ee5e2cbdc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff08bf68ffce2f4e0e74f8a39e49187e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df92d5576b3332ccfb12c67acdb4d9f
publicationDate 2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012047645-A3
titleOfInvention Combination treatment for rosacea
abstract The invention relates to a method of treating erythema and/or telangiectasia associated with rosacea in a patient in need thereof by topically administering an effective amount of a combination of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to the site of erythema and/or telangiectasia on the skin of the patient. The invention further relates to topical compositions including the combination of compounds and a pharmaceutically acceptable carrier.
priorityDate 2010-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004242588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010227867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130027-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412684

Total number of triples: 44.